Wentao Zhang

Key Laboratory Of Carcinogenesis And Cancer Invasion, Ministry Of Education, P.R. China
Zhongshan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion.

SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion.

Journal: Oncoimmunology
Published: July 11, 2024

PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy.

PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy.

Journal: Journal of hepatology
Published: March 27, 2021

High serum gamma-glutamyl transpeptidase concentration associates with poor postoperative prognosis of patients with hepatitis B virus-associated intrahepatic cholangiocarcinoma.

High serum gamma-glutamyl transpeptidase concentration associates with poor postoperative prognosis of patients with hepatitis B virus-associated intrahepatic cholangiocarcinoma.

Journal: Annals of translational medicine
Published: February 08, 2021

Association of intrinsic pathways with altered tumor immune infiltration in hepatocellular carcinoma: New targets for combining immune therapy.

Association of intrinsic pathways with altered tumor immune infiltration in hepatocellular carcinoma: New targets for combining immune therapy.

Journal: Clinical and translational medicine
Published: September 16, 2020

GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma.

GOLM1 upregulates expression of PD-L1 through EGFR/STAT3 pathway in hepatocellular carcinoma.

Journal: American journal of cancer research
Published: July 05, 2020

Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma.

Hepatoma cell-intrinsic TLR9 activation induces immune escape through PD-L1 upregulation in hepatocellular carcinoma.

Journal: Theranostics
Published: January 31, 2020

Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma.

Disulfiram combined with copper induces immunosuppression via PD-L1 stabilization in hepatocellular carcinoma.

Journal: American journal of cancer research
Published: September 11, 2019

Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.

Tumor Size Affects Efficacy of Adjuvant Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma and Microvascular Invasion.

Journal: The oncologist
Published: May 22, 2018

Low expression of WW domain-containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.

Low expression of WW domain-containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection.

Journal: Cancer medicine
Published: December 26, 2017

Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma.

Association of WWOX rs9926344 polymorphism with poor prognosis of hepatocellular carcinoma.

Journal: Journal of Cancer
Published: November 12, 2017

Integrated Analysis of Copy Number Variations and Gene Expression Profiling in Hepatocellular carcinoma.

Integrated Analysis of Copy Number Variations and Gene Expression Profiling in Hepatocellular carcinoma.

Journal: Scientific reports
Published: March 17, 2017

Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells.

Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells.

Journal: Cell biology and toxicology
Published: January 04, 2016
Showing 1-12 of 12

Last Updated: 09/26/2026